January 19, 2025 - 21:51

The stock market is bracing for a busy week of political news as Donald Trump returns to the Oval Office. With his inauguration on the horizon, investors are keenly watching for any signals that could influence market trends. This week coincides with the ongoing earnings season, where companies are reporting their financial results, adding another layer of complexity to the economic landscape.
Analysts are predicting that Trump's policies will have significant implications for various sectors, particularly in areas such as energy, healthcare, and technology. As businesses navigate the changing political environment, many are adjusting their forecasts based on potential shifts in regulation and taxation.
Market volatility is expected as traders react to both the earnings reports and the unfolding political developments. Investors are advised to stay informed and consider how these factors may impact their portfolios in the coming days. As the week progresses, the intersection of politics and finance will undoubtedly shape the market's trajectory.
August 29, 2026 - 00:42
Why Rubrik Stock Is Plummeting TodayShares of Rubrik took a sharp hit today, with the stock falling more than 12 percent in morning trading. The drop comes after the data security company reported quarterly results that showed a...
August 28, 2026 - 04:10
Michael Burry Thanks Tech Columnist’s Praise For Making ‘A Killing’ On NVDA, MSFT Calls Into EarningsInvestor Michael Burry, best known for betting against the housing market before the 2008 crash, has acknowledged a tech columnist`s compliment about his recent options trades. The acknowledgment...
August 27, 2026 - 21:27
Texas is on RBC's map to grow its City National Bank unitRoyal Bank of Canada is setting its sights on Texas as a key market for expanding its City National Bank subsidiary. Senior executives at the Toronto-based lender said they see strong organic...
August 27, 2026 - 11:07
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate UpdatesShanghai, August 26, 2026 - Shanghai Junshi Biosciences, a biopharmaceutical company focused on creating new treatments, has shared its financial results for the first half of 2026. The company...